124 related articles for article (PubMed ID: 38214572)
1. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profile of cancer stem cell-derived exosomes from patients with malignant melanoma.
Palacios-Ferrer JL; García-Ortega MB; Gallardo-Gómez M; García MÁ; Díaz C; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias-Santiago S; Amezcua V; Peinado H; Vicente F; Pérez Del Palacio J; Marchal JA
Mol Oncol; 2021 Feb; 15(2):407-428. PubMed ID: 33052601
[TBL] [Abstract][Full Text] [Related]
3. Untargeted LC-HRMS-Based Metabolomics for Searching New Biomarkers of Pancreatic Ductal Adenocarcinoma: A Pilot Study.
Ríos Peces S; Díaz Navarro C; Márquez López C; Caba O; Jiménez-Luna C; Melguizo C; Prados JC; Genilloud O; Vicente Pérez F; Pérez Del Palacio J
SLAS Discov; 2017 Apr; 22(4):348-359. PubMed ID: 27655283
[TBL] [Abstract][Full Text] [Related]
4. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
5. Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer.
Martín-Blázquez A; Díaz C; González-Flores E; Franco-Rivas D; Jiménez-Luna C; Melguizo C; Prados J; Genilloud O; Vicente F; Caba O; Pérez Del Palacio J
Sci Rep; 2019 Dec; 9(1):20198. PubMed ID: 31882610
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.
Bayci AWL; Baker DA; Somerset AE; Turkoglu O; Hothem Z; Callahan RE; Mandal R; Han B; Bjorndahl T; Wishart D; Bahado-Singh R; Graham SF; Keidan R
Metabolomics; 2018 Aug; 14(8):105. PubMed ID: 30830422
[TBL] [Abstract][Full Text] [Related]
7. Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics.
Pinto FG; Mahmud I; Harmon TA; Rubio VY; Garrett TJ
J Proteome Res; 2020 May; 19(5):2080-2091. PubMed ID: 32216312
[TBL] [Abstract][Full Text] [Related]
8. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
Hu C; Wang T; Zhuang X; Sun Q; Wang X; Lin H; Feng M; Zhang J; Cao Q; Jiang Y
J Transl Med; 2021 Apr; 19(1):152. PubMed ID: 33858428
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
10. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous untargeted and targeted metabolomics profiling of underivatized primary metabolites in sulfur-deficient barley by ultra-high performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
Ghosson H; Schwarzenberg A; Jamois F; Yvin JC
Plant Methods; 2018; 14():62. PubMed ID: 30061918
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.
Martín-Blázquez A; Jiménez-Luna C; Díaz C; Martínez-Galán J; Prados J; Vicente F; Melguizo C; Genilloud O; Pérez Del Palacio J; Caba O
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325731
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort.
Eggertsen PP; Hansen J; Andersen ML; Nielsen JF; Olsen RKJ; Palmfeldt J
J Pharm Biomed Anal; 2023 Apr; 227():115304. PubMed ID: 36827735
[TBL] [Abstract][Full Text] [Related]
15. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
16. Screening for reducing morbidity and mortality in malignant melanoma.
Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
[TBL] [Abstract][Full Text] [Related]
17. [Urine metabolomics analysis based on ultra performance liquid chromatography-high resolution mass spectrometry combined with osmolality calibration sample concentration variability].
He Z; Lin H; Gui J; Zhu W; He J; Wang H; Feng L
Se Pu; 2021 Apr; 39(4):391-398. PubMed ID: 34227759
[TBL] [Abstract][Full Text] [Related]
18. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
19. Untargeted LC-HRMS metabolomics reveals candidate biomarkers for mucopolysaccharidoses.
Torres CL; Scalco FB; de Oliveira MLC; Peake RWA; Garrett R
Clin Chim Acta; 2023 Feb; 541():117250. PubMed ID: 36764508
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
